FDA News
🇺🇸 FDA Page 14FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Track critical FDA approvals, regulatory updates, and policy shifts impacting drug development and market access in the US. Stay ahead of compliance.
Showing 157–168 of 391 articles
Lilly and Gilead Drive Pharma M&A Surge: A Strategic Market Analysis
FDA · cancer · 7 min
Dr. Sarah MitchellCandel's Prostate Cancer Drug: Long-Term Data Insights Ahead of FDA Filing
FDA · prostate cancer · 8 min
Dr. Sarah MitchellWhite House Taps Amazon, GoodRx to Expand TrumpRx Generic Drug Access
FDA · 7 min
Dr. Sarah MitchellSupreme Court Upholds Medicare Drug Price Negotiation: Implications for Pharma
FDA · 8 min
Dr. Sarah MitchellRetro Biosciences Secures $1.8 Billion Valuation in Landmark Longevity Funding Round
FDA · longevity · 10 min
Dr. Sarah MitchellFDA Approves Atezolizumab for ctDNA MRD-Positive MIBC: A New Era for Adjuvant Therapy
FDA · muscle invasive bladder cancer · 7 min
Dr. Sarah MitchellFDA Leadership Vacuum: Navigating Uncertainty for Pharmaceutical Business Development
FDA · 9 min
Dr. Sarah MitchellInventiva Bolsters Executive Team Ahead of Lanifibranor Phase 3 Data
FDA · 8 min
Dr. Sarah MitchellEli Lilly Acquires Engage Bio to Advance Non-Viral Genetic Medicines
FDA · genetic medicines · 7 min
Dr. Sarah MitchellEli Lilly's Strategic Vaccine Acquisitions: A New Era in Infectious Disease
FDA · vaccine · 6 min
Dr. Sarah MitchellWave Life Sciences' Monthly Dosing Strategy for AATD: A Competitive Analysis
FDA · AATD · 10 min
Dr. Sarah MitchellAmgen and Zai Lab Leadership Shifts: Strategic Implications for Pharma BD and Investors
FDA · neurology · 8 min
Dr. Sarah MitchellExplore intelligence